Companies: 10,795·Total market cap: $144.5T
Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc.

TCRTNASDAQHealthcare● Active
$2.00
$-0.28(-12.28%)
Market Cap$4884292
P/E Ratio
52W High$6.2
52W Low$1.67

Alaunos Therapeutics, Inc. (TCRT) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · TCRT · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Alaunos Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

TCRT insider buying and selling by quarter

TCRT insider selling · TCRT insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
192K96K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · TCRT ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

TCRT executive sell shares · TCRT board member insider trading · TCRT insider trading SEC filing

Showing 33 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Weis Holger

CEO

Award

Date

May 22

Shares

3,700

Price

$2.37

Value

$9K

View Form 4 on SEC.gov

Vieser Jaime

Director

Award

Date

Apr 29

Shares

6,515

Price

$2.59

Value

$17K

View Form 4 on SEC.gov

Postma Robert W

Director

Award

Date

Apr 29

Shares

6,274

Price

$2.59

Value

$16K

View Form 4 on SEC.gov

Jerman Michael Allen

Director

Award

Date

Apr 29

Shares

6,032

Price

$2.59

Value

$16K

View Form 4 on SEC.gov

Jerman Michael Allen

Director

Award

Date

Jan 12

Shares

5,406

Price

$2.89

Value

$16K

View Form 4 on SEC.gov

Postma Robert W

Director

Award

Date

Jan 12

Shares

5,622

Price

$2.89

Value

$16K

View Form 4 on SEC.gov

Vieser Jaime

Director

Award

Date

Jan 12

Shares

5,839

Price

$2.89

Value

$17K

View Form 4 on SEC.gov

Vieser Jaime

Director

Award

Date

Nov 21

Shares

5,340

Price

$3.16

Value

$17K

View Form 4 on SEC.gov

Postma Robert W

Director

Award

Date

Nov 21

Shares

5,142

Price

$3.16

Value

$16K

View Form 4 on SEC.gov

Jerman Michael Allen

Director

Award

Date

Nov 21

Shares

4,183

Price

$3.16

Value

$13K

View Form 4 on SEC.gov

Groenewald Ferdinand

Vice President of Finance

Award

Date

Aug 18

Shares

10,775

Price

Value

View Form 4 on SEC.gov

Postma Robert W

Director

Award

Date

Jul 3

Shares

4,050

Price

Value

View Form 4 on SEC.gov

Vieser Jaime

Director

Award

Date

Jul 3

Shares

3,400

Price

Value

View Form 4 on SEC.gov

Postma Robert W

Director

Award

Date

Apr 13

Shares

20,804

Price

$2.92

Value

$61K

View Form 4 on SEC.gov

Vieser Jaime

Director

Award

Date

Apr 13

Shares

17,465

Price

Value

View Form 4 on SEC.gov

Vieser Jaime

Director

Sale

Date

Dec 31

Shares

2,182

Price

$2.01

Value

$4K

View Form 4 on SEC.gov

Vieser Jaime

Director

Sale

Date

Dec 31

Shares

818

Price

$2.00

Value

$2K

View Form 4 on SEC.gov

Boyle Kevin S. Sr.

CEO · Director

Sale

Date

Sep 1

Shares

68,014

Price

$0.14

Value

$10K

View Form 4 on SEC.gov

Postma Robert W

Director

Purchase

Date

Nov 29

Shares

750,000

Price

$0.65

Value

$488K

View Form 4 on SEC.gov

Vieser Jaime

Director

Purchase

Date

Nov 29

Shares

1,250,000

Price

$0.65

Value

$813K

View Form 4 on SEC.gov

Boyle Kevin S. Sr.

CEO

Other

Date

Aug 30

Shares

18,750

Price

$2.41

Value

$45K

View Form 4 on SEC.gov

Thistle Mary

Director

Award

Date

Jun 22

Shares

40,000

Price

Value

View Form 4 on SEC.gov

Huang James

Director

Award

Date

Jun 22

Shares

80,000

Price

Value

View Form 4 on SEC.gov

Postma Robert W

Director

Award

Date

Jun 22

Shares

40,000

Price

Value

View Form 4 on SEC.gov

De Groot Eleanor

EVP, Operations

Sale

Date

Dec 22

Shares

20,132

Price

$1.27

Value

$26K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About TCRT insider trading

TCRT insider trades

Alaunos Therapeutics, Inc. (TCRT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Vieser Jaime (Director), Postma Robert W (Director), Jerman Michael Allen (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. TCRT insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Alaunos Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

TCRT insider trading · 5 questions

The insiders of Alaunos Therapeutics, Inc. (TCRT) include executives and directors such as Vieser Jaime (Director), Postma Robert W (Director), Jerman Michael Allen (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

TCRT board member insider tradingwho are TCRT insidersTCRT insider rosterAlaunos Therapeutics, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026